Use of dronedarone or a pharmaceutically acceptable salt thereof for drug manufacture to be administered immediately after amiodarone withdrawal

摘要

The present invention concerns the use of dronedarone or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for use in the prevention and/or treatment of patients with atrial fibrillation (AF) or atrial Flutter (AFL), shortly after discontinuation of a previous treatment with amiodarone.